BACKGROUND: One major advantage of automated over manual clamps are continuous measurements of blood glucose concentrations (BG) allowing frequent adaptations in glucose infusion rates (GIR). However, BG measurements might be affected by changes in blood dilution. ClampArt®, a modern automated clamp device, corrects BG measurements for blood dilution, but the impact of this correction is unclear. METHODS: The authors performed a retrospective analysis of BG during glucose clamps comparing values with a fixed dilution factor with those corrected for the actual blood dilution. RESULTS: Clamp quality substantially improved with the consideration of blood dilution: Mean accuracy fell from 8.1% ± 2.9% to 4.1% ± 0.8%, precision improved from 9.6 ± 3.6 mg/dl to 3.7 ± 1.3 mg/dl and control deviation from -2.6 ± 4.2 mg/dl to 0.2 ± 0.2 mg/dl. CONCLUSIONS: Correcting continuous BG measurements for blood dilution significantly increases BG measurement and clamp quality.
BACKGROUND: One major advantage of automated over manual clamps are continuous measurements of blood glucose concentrations (BG) allowing frequent adaptations in glucose infusion rates (GIR). However, BG measurements might be affected by changes in blood dilution. ClampArt®, a modern automated clamp device, corrects BG measurements for blood dilution, but the impact of this correction is unclear. METHODS: The authors performed a retrospective analysis of BG during glucose clamps comparing values with a fixed dilution factor with those corrected for the actual blood dilution. RESULTS: Clamp quality substantially improved with the consideration of blood dilution: Mean accuracy fell from 8.1% ± 2.9% to 4.1% ± 0.8%, precision improved from 9.6 ± 3.6 mg/dl to 3.7 ± 1.3 mg/dl and control deviation from -2.6 ± 4.2 mg/dl to 0.2 ± 0.2 mg/dl. CONCLUSIONS: Correcting continuous BG measurements for blood dilution significantly increases BG measurement and clamp quality.
Entities:
Keywords:
ClampArt; clamp quality; control deviation; glucose clamp; pharmacodynamics; type 1 diabetes
Authors: H Greiner; R Schaller-Ammann; A Huber; M O'Connell; J Krejci; G Porro; S Korsatko; J Gurban; S Deller; M Brunner; A Berghofer; J Priedl; E Zijlstra; T Heise; T R Pieber; L Schaupp Journal: Biomed Tech (Berl) Date: 2013-09-07 Impact factor: 1.411
Authors: T S Bailey; J Pettus; R Roussel; W Schmider; M Maroccia; N Nassr; O Klein; G B Bolli; R Dahmen Journal: Diabetes Metab Date: 2017-11-16 Impact factor: 6.041